Drug data last refreshed 22h ago · AI intelligence enriched 4d ago
Zinc sulfate is an intravenous solution containing zinc, an essential trace mineral required for immune function, wound healing, and protein synthesis. It is used as a nutritional supplement in patients unable to obtain adequate zinc through oral intake, particularly in parenteral nutrition regimens. The drug replaces deficient zinc levels to support normal physiological processes.
Product is at peak commercial stage with moderate competitive pressure (30%), suggesting stable team size and focus on market maintenance rather than rapid expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Working on zinc sulfate positions professionals in a stable, mature product portfolio at Bristol Myers Squibb with focus on hospital/critical care channels and formulary management. Career progression emphasizes operational excellence, healthcare economics, and parenteral nutrition expertise rather than breakthrough innovation.
Worked on ZINC SULFATE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.